Soleus Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,127,043
Closed -$51.8M 114
2023
Q1
$51.8M Buy
2,127,043
+12,315
+0.6% +$270K 5.36% 3
2022
Q4
$45.3M Sell
2,114,728
-387,873
-15% -$8.28M 6.5% 2
2022
Q3
$44.9M Buy
2,502,601
+1,588,255
+174% +$20.8M 6.1% 2
2022
Q2
$8.8M Sell
914,346
-50,130
-5% -$629K 1.37% 26
2022
Q1
$16.2M Sell
964,476
-103,900
-10% -$1.54M 2.09% 17
2021
Q4
$17.9M Sell
1,068,376
-24,644
-2% -$404K 1.79% 22
2021
Q3
$17.8M Sell
1,093,020
-1,715,323
-61% -$18.7M 2.77% 12
2021
Q2
$17.7M Sell
2,808,343
-572,636
-17% -$3.69M 2.73% 9
2021
Q1
$20.9M Buy
3,380,979
+1,783,700
+112% +$10.8M 3.76% 4
2020
Q4
$11M Sell
1,597,279
-88,600
-5% -$567K 1.46% 5
2020
Q3
$9.51M Buy
1,685,879
+59,178
+4% +$282K 5.04% 2
2020
Q2
$8.3M Buy
1,626,701
+19,548
+1% +$81.4K 4.73% 4
2020
Q1
$5.53M Buy
1,607,153
+938,782
+140% +$5.49M 6.43% 3
2019
Q4
$5.73M Buy
+668,371
New +$2.39M 5.53% 4

Other funds holding ISEE

Soleus Capital Management's ISEE Position: Q2 2023 in Review

Soleus Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 2,127,043 shares — an estimated $51.8M sold.

Soleus Capital Management first reported a position in ISEE in Q4 2019 and held it in 14 quarters. The position peaked at $51.8M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Soleus Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Soleus Capital Management sold 2,127,043 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $51.8M.
  • Soleus Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 14 quarters.
  • Soleus Capital Management's IVERIC bio, Inc. Common Stock position peaked at $51.8M in Q1 2023.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Soleus Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.